Head-to-head · WeighScore
AbundRX vs NuviaRx
The verdict
NuviaRx takes it — 73.5/100 to 66.6/100.
NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AbundRX | NuviaRx |
|---|---|---|
| WeighScore | 66.6/100 | 73.5/100 |
| Grade | C | C |
| Scorecard rank | #181 | #69 |
| Semaglutide | $179/mo (compounded) | $140/mo (all doses, compounded) |
| Tirzepatide | $279/mo (compounded) | $170/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #181 · C
Strengths
- Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
- Fast, free shipping and a simple few-minute online health assessment
- Provider-guided care connecting patients with licensed US clinicians
- Publishes Terms, Privacy, and Refund policies
Where it loses points
- Claims LegitScript certification in text but displays no verifiable seal or listing
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Compounding pharmacy not named; no HIPAA notice found; state availability not published
- Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Graded #69 · C
Strengths
- Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
- Free delivery included; clinical evaluation and prescription bundled (if eligible)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
- Named operating entity (NuviaRx Health Inc.) with a US address and phone support
Where it loses points
- Compounding pharmacy partner not named ('partner pharmacy')
- Not LegitScript-certified (no certification displayed)
- Lowest pricing is 'as low as' — likely requires a longer prepaid plan
- State availability not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.